# ABRILADA

NDC: 0025-0328
Generic name: adalimumab-afzb
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20231214

FDA application: BLA761118

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0025-0328"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0025-0328
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ef1c7cf-466f-495e-8d13-82e2ddfa7a4f